The present invention relates to caps for medical connectors, and more particularly to caps that can be used to protect the sterility of unconnected male luer connectors, such as male luer connectors that may be used for fluid flow or for fluid delivery systems.
Disclosed herein are disinfecting caps, and related systems and methods, that can reduce the threat of microorganisms entering the bloodstream of a patient via fluid flow or fluid delivery systems, such as, for example, needleless injection sites and/or fluid transfer devices having an elongated male portion or male protrusion, such as, for example, a male luer. The disinfecting caps have vents that reduce the time of exposure of the male luer to disinfectant.
In a first embodiment of the invention there is provided a male-disinfecting cap configured to couple with and apply an antiseptic agent to medical male luer-lock connector of the type including a post having a lumen. The male luer-lock connector also has an internally helically threaded skirt surrounding the post. The cap includes a receiving portion which defines a chamber. The post of the male luer-lock connector is received into a single opening of the chamber. The receiving portion is configured to fit within the skirt of the male luer-lock connector when the post is received into the receiving portion. The receiving portion has an internal surface and an external surface. At least one vent is defined on the internal surface of the receiving portion and extends from the opening into the chamber, where an antiseptic is disposed. Protrusions on the external surface of the receiving portion engage helical threads of the internally helically threaded skirt. The male-disinfecting cap also includes a seal that prevents evaporation of the antiseptic agent in the chamber prior to use.
In another embodiment, a method of disinfecting a male luer-lock connector of the type having a post with a lumen through which fluid flows and an internally helically threaded skirt surrounding the post includes providing a male-disinfecting cap. The male-disinfecting cap has a receiving portion defining a chamber into which the post of the male luer-lock connector can be received. The chamber has a single opening. The receiving portion has an external surface and is configured to fit within the skirt of the male luer-lock connector when the post is received into the receiving portion. The internal surface defines at least one vent. The vent extends from the opening into the chamber. An antiseptic agent is disposed in the chamber. The method includes engaging protrusions on the external surface of the receiving portion with helical threads of the internally helically threaded skirt. The method also includes undoing a seal which prevents evaporation of the antiseptic agent in the chamber prior to use so as to permit the opening to receive the post. The method also moves the cap in relation to the male luer-lock connector so that the antiseptic agent comes into contact with the post.
The foregoing features of embodiments will be more readily understood by reference to the following detailed description, taken with reference to the accompanying drawings, in which:
Definitions. As used in this description and the accompanying claims, the following terms shall have the meanings indicated, unless the context otherwise requires:
“NIS”—Needleless Injection Site (sometimes called LAV).
“LAV”—Luer Access Valve (also called NIS). A “LAV” is supposed to be made in conformity with industry standards for a luer. A NIS may be made in conformance with industry standards for a luer, but may not be; instead the NIS may be made in conformance with a manufacturer-specific, non-industry-standard specification.
A male connector to be disinfected by the present invention may be designed for use with a NIS, or more particularly for use with a LAV.
The terms “proximal” and “distal,” when used herein relative to a cap, are such that an NIS or LAV is inserted into a proximal end of the cap and advanced toward a distal end of the cap.
In illustrative embodiments, a male-disinfecting cap has vents which allow for faster evaporation of disinfectant inside the cap. Specifically, the male-disinfecting caps frequently have disinfectant inside of them, and a seal on an exterior surface which prevents evaporation of the disinfectant. When the cap is mated with a male connector, the seal must be removed. Because of the tight fit in a luer-fit connection, the disinfectant within the cap evaporates slowly, if at all. Illustrative embodiments of the invention have vents which provide faster evaporation of the disinfectant.
The cap 104 defines an extension, elongated portion, receiving portion or projection 155 that extends proximally from the main body 136 of the cap housing 150. The receiving portion 155 is configured to couple with a medical connector that includes a male protrusion. The male luer passes through an opening formed by a proximal surface 159 of the receiving portion 155 and couples with the cap 104. The receiving portion 155 includes a connection interface that is configured to effect the coupling. In the illustrated embodiment, the receiving portion 155 is substantially cylindrical, and the connection interface comprises one or more threads 143 that are positioned at an outwardly facing surface of the cylinder. Any other suitable connection interface is possible. Those having skill in the art will know how to size the receiving portion 155 to accept industry standard male luer connectors. A person having skill in the art would also know how to size threads 143 for corresponding threading engagement between the external threads 143 of the cap 104 and the internal threads of a skirt of a male connector.
The housing 150 may have a graspable part 137. The graspable part 137 can assist a user by providing a surface to which torque can be applied for threading engagement and disengagement of the cap 104 to a male luer. The graspable part 137 be an extension of the body 136 and may be positioned at the distal end 124 of the cap 104. The graspable part 137 can comprise any suitable gripping features 103, which in illustrated embodiments comprise opposing gripping regions or grasping platforms 138 that are configured to provide a convenient surface against which a user can press so as to hold and/or twist the cap 104.
The receiving portion 155 of the cap 104 has a vent 188 or a plurality of vents 188. These vents 188 allow for faster evaporation of disinfectant while the cap 104 is connected with a male connector than do traditional male caps. The vents 188 comprise channels that run along at least part of the tapered surface 157 of the receiving portion 155. Those having skill in the art will understand that the number of vents 188 is not limited to the number herein described. Some embodiments have a single vent 188. Other embodiments have more than one vent 188. For example, some embodiments have one, four or eight vents 188. Vents 188 may be straight or angled. The vents 188 may have different dimensions and/or angles. In a first preferred embodiment as shown, the vents 188 are straight. In this embodiment, there are four vents 188 spaced equidistantly around the tapered surface 157 of the receiving portion 155. The vents 188 run from the proximal end 122 of the receiving portion 155 towards a chamber inside the housing 150.
Generally, the male luer tip of a medical connector forms a fluid-tight seal with the receiving portion 155 of the cap 104 when the two are engaged. This fluid-tight seal is formed in the sense that fluid is not generally able to flow around the luer tip to the atmosphere (i.e., the ambient pressure outside of the cap). At least part of the interior of the receiving portion 155 may be shaped complementarily to an outer surface of a male luer tip of a medical connector with which the male cap 104 is configured to be used. For example, the interior of the receiving portion 155 may form a substantially frustoconical tapered surface 157 that complies with ISO luer standards, such that a portion of a male luer can form a seal. The frustoconical tapered surface 157 is preferably tapered so as to decrease in diameter in the distal direction. In some embodiments, the vents 188 may be cut into the frustoconical tapered surface 157 of the receiving portion 155.
After the intermediate region 173, the tapered surface 157 is formed towards the proximal end. The inner diameter formed between the tapered surface 157 widens towards the proximal end 122. The inner diameter is at its narrowest right along the interface of the intermediate region 173. As can be seen, in some embodiments, the vent 188 runs along the entire length of the tapered surface 157. Each vent 188 provides a channel through which disinfectant inside the cap 104 can communicate with the external atmosphere when the cap and the male luer are engaged.
In a similar manner, the depth 187 of the vent 188 does not have to be consistent throughout the entirety of the vent 188. For example, the depth 187 of the vent 188 may increase towards the distal end 124. The increase in the depth 187 may be proportional to the decrease of the inner diameter. For example, the inner diameter formed by the tapered surface 157 tapers towards the distal end to meet conventional ISO luer standards. In some embodiments, the increase in depth 187 of the vent 188 towards the distal end 124 may be exactly the same as the decrease of the size of the inner diameter towards the distal end 124.
Those skilled in the art will understand that the depth 187, width 189 and length 191 are variable. Furthermore, the size of the depth 187 and the width 189 may be inversely proportional. As the depth 187 increases the width 189 may be proportionately decreased. The vents 188 allow for faster evaporation of gaseous particles of the disinfectant within the cap 104 than caps without vents. In some embodiments, the vents 188 may be sized sufficiently so that liquid disinfectant is able to flow through the vents 188.
It should be understood that although specific dimensions have been provided, other dimensions may be used. Different vent 188 dimensions cause different rates of evaporation. The longer and narrower the vent is, the slower the rate of evaporation and the less likely that airborne contaminants will make it into the chamber. In some embodiments, the vents may be configured so that substantial evaporation may have occurred 1.5 hours after engagement with a male connector.
Similar to the straight vents 288, each angled vent 288 has a width, a depth and a length. These dimensions are relative to the tapered surface 157 of the receiving region 155. In a preferred embodiment, each vent 288 has identical dimensions. In another preferred embodiment, each vent 288 has the same width. In another preferred embodiment, each vent 288 has the same depth. In another preferred embodiment, each vent 288 has the same length. The angled vents 288 preferably have a width of 0.020″ and a depth of 0.010″. In some embodiments, the angled vents 288 have consistent width and depth along their entirety. However, in some embodiments, the angled vents 288 have tapered widths and tapered depths. Accordingly, the vents 288 are not required to have consistent dimensions throughout their entirety. For example, the width of the vent 288 may increase towards the proximal end 122 of the cap 106. Male luer connectors generally have precise taper dimensions. For that reason, the inner diameter formed by the tapered surface 157 fits to the taper of the male luer connector and becomes smaller as it approaches the distal end 124 of the cap 104. The width may vary proportionally along the tapered surface 157 as the size of the inner diameter varies. However, in some other embodiments, the width may be consistent throughout the entirety of the vent 288.
The length of the vent 288 is affected by the angle A. If the angle A increases, than the vent 288 length becomes shorter. If the angle A decreases, than the vent 288 length becomes longer.
An outer edge of a proximal surface of the movable member 190 can define a greater outer diameter than a minimum inner diameter of the shelf 174 such that the shelf 174 can maintain the movable member 190 within the chamber 158. The shelf 174 also can cooperate with the movable member 190 to close the chamber 158 when the assembly 100 is in the preuse state, as further discussed below.
In the illustrated embodiment, a long distal extension 175 of the disinfection chamber 158 can extend distally from the shelf 174. The distal extension 175 has a slightly tapered outer boundary 179 that gradually decreases in cross-sectional area in the distal direction 124. The disinfection chamber 158 can include a support column 168 within a distal region thereof. The support column 168 can be integrally formed with both a base wall 154 and the sidewall 152, and can provide a rigid surface against which the rod 177 can rest. The support column 168 can act as a stop that prevents the rod 177 from moving distally within the chamber 122 past a proximal end of the column 168. In some instances, however, a distal portion of the rod 177 may deform so as to extend distally slightly past the proximal end of the support column 168 when a medical connector is coupled with the cap 108. The support column 168 can reduce the amount of material that might otherwise be used to form the graspable part 137 of the cap 108.
The rod 177, which may also be referred to as a support or a base element, can be configured to provide a base against which the antiseptic reservoir or pad 170 can be compressed so as to force antiseptic therefrom. Accordingly, the rod 177 can be harder, stiffer, or less compliant than the pad 170, and can be configured to compress, under a given force, to a smaller extent than the pad 170 does under the same force. For example, in various embodiments, the rod 177 can be no less than about 2, 3, or 4 times harder than the pad 170.
The rod 177 can be elastically deformable such that compression of the rod 177 from a relaxed orientation gives rise to a restorative force. The rod 177 can naturally return to the relaxed orientation upon removal of the compressive force. The rod 177 can comprise any suitable elastically deformable material. In some embodiments, the rod 177 comprises an elastomeric material, such as silicone. In certain embodiments, the rod 177 comprises a closed configuration (e.g., closed cell foam) or is otherwise nonabsorbent such that little or no antiseptic 133 that is expelled from the pad 170 is received into the rod 177. In other or further embodiments, the rod 177 may comprise a spring (e.g., a compression coil spring).
In the illustrated embodiment, a distal end of the rod 177 seats snugly against the inner surface 166 of the cap 108. The rod 177 may form a fluid-tight seal with the inner surface 166, which may prevent antiseptic 133 that is expelled from the pad 170 from migrating into the distal regions of the disinfecting chamber 158. Rather, the antiseptic 133 can be restrained to the proximal regions of the disinfecting chamber 158 where it can be urged into contact with a male protrusion of a medical connector 1100.
The pad 170 can comprise any suitable material, such as those described above with respect to other pads (including plastically deformable materials, in some instances), and may be elastically or resiliently deformable. In some embodiments, the pad 170 is attached to the rod 177 via any suitable adhesive or other attachment mechanism, although in other embodiments, no such attachment mechanisms are used. For example, the pad 170 and the rod 177 may be maintained in contact with each other due to a slight longitudinal compression of one or more of these components once the cap 104 is assembled (e.g., once the rod 177, the pad 170, and the movable member 190 are positioned between the support column 168 and the shelf 174). Similarly, the pad 170 may be attached to the movable member 190, or it may maintain a substantially fixed orientation relative to the movable member 190 without such attachment due to the resilience of the pad 170 and/or the rod 177, which are in a slightly compressed state.
In
The vents allow the antiseptic agent to evaporate by providing limited exposure of the cap's chamber to the atmosphere.
For the helical-vent embodiment, the preferred number of vents is 2. The straight-vent embodiments preferably have 4 vents. Alternatively, a straight-vent cap has 8 vents, although both helical-vent and straight-vent caps may have any number of vents that can fit around the circumference of opening, including only a single vent per cap.
Alternative structures, aside from those described above, may be used to vent the chamber to atmosphere after the seal is removed and when the post of the male luer-lock connector is being engaged by the receiving portion. For example, bumps may be located on the inner surface of the cap's receiving portion for keeping open a passage between this inner surface and the outer surface of an inserted male luer tip. This passage allows venting of the cap's chamber to atmosphere. Another alternative structure may include a larger inner diameter of the receiving portion of the cap. In such an arrangement, ribs may be placed on the inner surface of the receiving portion in order to keep the inserted luer tip spaced away from the inner surface of the receiving portion. In a further example, the receiving portion of the cap may include an oval-shaped opening to vent the cap's chamber to atmosphere.
The embodiments of the invention described above are intended to be merely exemplary; numerous variations and modifications will be apparent to those skilled in the art. All such variations and modifications are intended to be within the scope of the present invention as defined in any appended claims.
This application is a continuation of International Application No. PCT/US2016/062061 filed on Nov. 15, 2016 which claims the benefit of U.S. Provisional Application No. 62/255,724 filed Nov. 16, 2015, the entire contents of each of which are hereby incorporated by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 1744026 | Baltzley | Oct 1926 | A |
| 1868200 | Freedman | Jul 1932 | A |
| 2356969 | Blum | May 1942 | A |
| 2299037 | Saueressig | Oct 1942 | A |
| 2351804 | Blum | Jun 1944 | A |
| 3315830 | Flynn | Apr 1967 | A |
| 3431548 | Busler | Mar 1969 | A |
| 3446596 | Salivar et al. | May 1969 | A |
| 3976311 | Spendlove | Aug 1976 | A |
| 3987930 | Fuson | Oct 1976 | A |
| 4121727 | Robbins et al. | Oct 1978 | A |
| 4232677 | Leibinsohn | Nov 1980 | A |
| 4299330 | Walter | Nov 1981 | A |
| 4324239 | Gordon et al. | Apr 1982 | A |
| 4334551 | Pfister | Jun 1982 | A |
| 4344551 | Pfister | Jun 1982 | A |
| 4340052 | Dennehey et al. | Jul 1982 | A |
| 4346703 | Dennehey et al. | Aug 1982 | A |
| 4354490 | Rogers | Oct 1982 | A |
| 4369781 | Gilson et al. | Jan 1983 | A |
| 4402691 | Rosenthal et al. | Sep 1983 | A |
| 4432764 | Lopez | Feb 1984 | A |
| 4432766 | Bellotti et al. | Feb 1984 | A |
| 4440207 | Genatempo et al. | Apr 1984 | A |
| 4450624 | Collier | May 1984 | A |
| 4572373 | Johansson | Feb 1986 | A |
| 4597758 | Aalto et al. | Jul 1986 | A |
| 4624664 | Peluso et al. | Nov 1986 | A |
| 4667837 | Vitello et al. | May 1987 | A |
| 4671306 | Spector | Jun 1987 | A |
| 4778447 | Velde et al. | Oct 1988 | A |
| 4798303 | Arnold | Jan 1989 | A |
| 4810241 | Rogers | Mar 1989 | A |
| 4838875 | Somor | Jun 1989 | A |
| D303631 | Demarest | Sep 1989 | S |
| D310542 | Regnault | Sep 1990 | S |
| 4991629 | Ernesto et al. | Feb 1991 | A |
| 5006114 | Rogers et al. | Apr 1991 | A |
| 5184742 | Decaprio et al. | Feb 1993 | A |
| D333788 | Geschwender | Mar 1993 | S |
| 5190534 | Kendell | Mar 1993 | A |
| 5195957 | Tollini | Mar 1993 | A |
| 5205821 | Kruger et al. | Apr 1993 | A |
| 5242425 | White et al. | Sep 1993 | A |
| D340112 | Zeman | Oct 1993 | S |
| D341227 | Lang et al. | Nov 1993 | S |
| 5269771 | Thomas et al. | Dec 1993 | A |
| 5385372 | Utterberg | Jan 1995 | A |
| 5439451 | Collinson et al. | Aug 1995 | A |
| 5445270 | Dratz | Aug 1995 | A |
| 5451113 | Lund et al. | Sep 1995 | A |
| 5466219 | Lynn et al. | Nov 1995 | A |
| 5492147 | Challender et al. | Feb 1996 | A |
| 5536258 | Folden | Jul 1996 | A |
| 5554135 | Menyhay | Sep 1996 | A |
| 5620427 | Werschmidt et al. | Apr 1997 | A |
| 5694978 | Heilmann et al. | Dec 1997 | A |
| 5702017 | Goncalves | Dec 1997 | A |
| 5738663 | Lopez | Apr 1998 | A |
| 5792120 | Menyhay | Aug 1998 | A |
| 5894015 | Rechtin | Apr 1999 | A |
| 5951519 | Utterberg | Sep 1999 | A |
| 5954657 | Rados | Sep 1999 | A |
| 5954957 | Chin-Loy et al. | Sep 1999 | A |
| 6045539 | Menyhay | Apr 2000 | A |
| 6152913 | Feith et al. | Nov 2000 | A |
| 6171287 | Lynn et al. | Jan 2001 | B1 |
| D456668 | Tse | May 2002 | S |
| D468015 | Horppu | Dec 2002 | S |
| D470888 | Kuboshima | Feb 2003 | S |
| 6523686 | Bae | Feb 2003 | B1 |
| 6932795 | Lopez et al. | Aug 2005 | B2 |
| 6960191 | Howlett et al. | Nov 2005 | B2 |
| 7014169 | Newton et al. | Mar 2006 | B2 |
| 7040598 | Raybuck | May 2006 | B2 |
| 7040669 | Kenmotsu et al. | May 2006 | B2 |
| 7198611 | Connell et al. | Apr 2007 | B2 |
| D545964 | Blanco | Jul 2007 | S |
| D547446 | Racz et al. | Jul 2007 | S |
| D550355 | Racz et al. | Sep 2007 | S |
| 7282186 | Lake, Jr. et al. | Oct 2007 | B2 |
| 7316669 | Ranalletta | Jan 2008 | B2 |
| D573643 | Brigham et al. | Jul 2008 | S |
| D607325 | Rogers et al. | Jan 2010 | S |
| 7762524 | Cawthon et al. | Jul 2010 | B2 |
| 7762988 | Vitello | Jul 2010 | B1 |
| 7763006 | Tennican | Jul 2010 | B2 |
| 7780794 | Rogers et al. | Aug 2010 | B2 |
| D632574 | Huntington et al. | Feb 2011 | S |
| 7922701 | Buchman | Apr 2011 | B2 |
| D639421 | Sano et al. | Jun 2011 | S |
| 7985302 | Rogers et al. | Jul 2011 | B2 |
| 8167847 | Anderson et al. | May 2012 | B2 |
| 8172825 | Solomon et al. | May 2012 | B2 |
| 8177761 | Howlett et al. | May 2012 | B2 |
| 8197749 | Howlett et al. | Jun 2012 | B2 |
| 8231587 | Solomon et al. | Jul 2012 | B2 |
| 8231602 | Anderson et al. | Jul 2012 | B2 |
| 8273303 | Ferlic et al. | Sep 2012 | B2 |
| 8328767 | Solomon et al. | Dec 2012 | B2 |
| 8343112 | Solomon et al. | Jan 2013 | B2 |
| 8419713 | Solomon et al. | Apr 2013 | B1 |
| 8523830 | Solomon et al. | Sep 2013 | B2 |
| 8523831 | Solomon et al. | Sep 2013 | B2 |
| 8641681 | Solomon et al. | Feb 2014 | B2 |
| 8647308 | Solomon et al. | Feb 2014 | B2 |
| 8647326 | Solomon et al. | Feb 2014 | B2 |
| 8740864 | Hoang | Jun 2014 | B2 |
| 8784388 | Charles et al. | Jul 2014 | B2 |
| 8808637 | Ferlic | Aug 2014 | B2 |
| 8961475 | Solomon et al. | Feb 2015 | B2 |
| 9079692 | Solomon et al. | Jul 2015 | B2 |
| 9101750 | Solomon et al. | Aug 2015 | B2 |
| 9114915 | Solomon et al. | Aug 2015 | B2 |
| 9242084 | Solomon et al. | Jan 2016 | B2 |
| 9352140 | Kerr et al. | May 2016 | B2 |
| 20020093192 | Matkovich | Jul 2002 | A1 |
| 20030140441 | Stafford | Jul 2003 | A1 |
| 20030153865 | Connell et al. | Aug 2003 | A1 |
| 20030181849 | Castellanos | Sep 2003 | A1 |
| 20030198502 | Maloney et al. | Oct 2003 | A1 |
| 20040039341 | Ranalletta | Feb 2004 | A1 |
| 20040195136 | Young et al. | Oct 2004 | A1 |
| 20040201216 | Segal et al. | Oct 2004 | A1 |
| 20040214316 | O'Connell | Oct 2004 | A1 |
| 20040258560 | Lake, Jr. et al. | Dec 2004 | A1 |
| 20050033267 | Decaria | Feb 2005 | A1 |
| 20050038397 | Newton et al. | Feb 2005 | A1 |
| 20050124970 | Kunin et al. | Jun 2005 | A1 |
| 20050147524 | Bousquet | Jul 2005 | A1 |
| 20050183971 | Petricca | Aug 2005 | A1 |
| 20050203460 | Kim | Sep 2005 | A1 |
| 20050245883 | Baldwin | Nov 2005 | A1 |
| 20050265773 | De Laforcade | Dec 2005 | A1 |
| 20050266714 | Higgins et al. | Dec 2005 | A1 |
| 20060030827 | Raulerson et al. | Feb 2006 | A1 |
| 20060177250 | Nakagaki | Aug 2006 | A1 |
| 20070112333 | Hoang et al. | May 2007 | A1 |
| 20070202177 | Hoang | Aug 2007 | A1 |
| 20070282280 | Tennican | Dec 2007 | A1 |
| 20070287989 | Crawford et al. | Dec 2007 | A1 |
| 20070293818 | Stout et al. | Dec 2007 | A1 |
| 20070293822 | Crawford et al. | Dec 2007 | A1 |
| 20080019889 | Rogers et al. | Jan 2008 | A1 |
| 20080021381 | Lurvey et al. | Jan 2008 | A1 |
| 20080027399 | Harding et al. | Jan 2008 | A1 |
| 20080033371 | Updefraff et al. | Feb 2008 | A1 |
| 20080038167 | Lynn | Feb 2008 | A1 |
| 20080039803 | Lynn | Feb 2008 | A1 |
| 20080097407 | Plishka | Feb 2008 | A1 |
| 20080086091 | Anderson et al. | Apr 2008 | A1 |
| 20080095680 | Steffens et al. | Apr 2008 | A1 |
| 20080105704 | Pritchard | May 2008 | A1 |
| 20080107564 | Sternberg et al. | May 2008 | A1 |
| 20080132880 | Buchman | Jun 2008 | A1 |
| 20080147047 | Davis et al. | Jun 2008 | A1 |
| 20080177250 | Howlett et al. | Jul 2008 | A1 |
| 20080190485 | Guala | Aug 2008 | A1 |
| 20080235888 | Vaillancourt et al. | Oct 2008 | A1 |
| 20090008393 | Howlett et al. | Jan 2009 | A1 |
| 20090062766 | Howlett et al. | Mar 2009 | A1 |
| 20090099529 | Anderson et al. | Apr 2009 | A1 |
| 20090149819 | Chelak | Jun 2009 | A1 |
| 20090205151 | Fisher et al. | Aug 2009 | A1 |
| 20100003067 | Shaw et al. | Jan 2010 | A1 |
| 20100047123 | Solomon et al. | Feb 2010 | A1 |
| 20100049170 | Solomon et al. | Feb 2010 | A1 |
| 20100063482 | Mansour et al. | Mar 2010 | A1 |
| 20100100056 | Cawthon et al. | Apr 2010 | A1 |
| 20100242993 | Hoang et al. | Sep 2010 | A1 |
| 20100306938 | Rogers et al. | Dec 2010 | A1 |
| 20100313366 | Rogers et al. | Dec 2010 | A1 |
| 20110044850 | Solomon et al. | Feb 2011 | A1 |
| 20110054440 | Lewis | Mar 2011 | A1 |
| 20110064512 | Shaw et al. | Mar 2011 | A1 |
| 20110165020 | Truggvason | Jul 2011 | A1 |
| 20110213341 | Solomon et al. | Sep 2011 | A1 |
| 20110217212 | Solomon et al. | Sep 2011 | A1 |
| 20110232020 | Rogers et al. | Sep 2011 | A1 |
| 20110277788 | Rogers et al. | Nov 2011 | A1 |
| 20110314619 | Schweikert | Dec 2011 | A1 |
| 20120016318 | Hoang et al. | Jan 2012 | A1 |
| 20120039764 | Solomon | Feb 2012 | A1 |
| 20120039765 | Solomon | Feb 2012 | A1 |
| 20120082977 | Rajagopal et al. | Apr 2012 | A1 |
| 20120216359 | Rogers et al. | Aug 2012 | A1 |
| 20130019421 | Rogers et al. | Jan 2013 | A1 |
| 20130072908 | Solomon et al. | Mar 2013 | A1 |
| 20130171030 | Ferlic et al. | Jul 2013 | A1 |
| 20130197485 | Gardner et al. | Aug 2013 | A1 |
| 20140010481 | Last et al. | Jan 2014 | A1 |
| 20140135739 | Solomon et al. | May 2014 | A1 |
| 20140227144 | Liu et al. | Aug 2014 | A1 |
| 20150231384 | Ma et al. | Aug 2015 | A1 |
| 20150273199 | Adams et al. | Oct 2015 | A1 |
| 20150374968 | Solomon et al. | Dec 2015 | A1 |
| 20160038701 | White et al. | Feb 2016 | A1 |
| 20160045629 | Gardner et al. | Feb 2016 | A1 |
| 20160106968 | Solomon et al. | Apr 2016 | A1 |
| 20170245618 | Chen et al. | Aug 2017 | A1 |
| 20190099593 | Avula et al. | Apr 2019 | A1 |
| 20190209781 | Solomon et al. | Jul 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 205549223 | Sep 2016 | CN |
| 0229786 | Jul 1987 | EP |
| 0462355 | Dec 1991 | EP |
| 64002760 | Jan 1989 | JP |
| 2004035245 | Apr 2004 | WO |
| 2006099306 | Sep 2006 | WO |
| 2008089196 | Jul 2008 | WO |
| 2008100950 | Aug 2008 | WO |
| 2010002808 | Jan 2010 | WO |
| 2010141508 | Dec 2010 | WO |
| 2011141508 | Dec 2010 | WO |
| 2011053924 | May 2011 | WO |
| 2011066565 | Jun 2011 | WO |
| 2011066586 | Jun 2011 | WO |
| 2013184716 | Dec 2013 | WO |
| 2015174953 | Nov 2015 | WO |
| Entry |
|---|
| International Search Report and Written Opinion dated Jun. 22, 2018 for PCT/US2018/014237. |
| Office Action dated May 25, 2018 for U.S. Appl. No. 15/203,002. |
| Office Action dated Jun. 7, 2018 for U.S. Appl. No. 14/947,241. |
| International Search Report and Written Opinion dated Jan. 24, 2019 for PCT/US2018/054202. |
| European Search Report dated Mar. 6, 2012 for EP08727689.5. |
| European Search Report dated Jun. 20, 2017 for EP10827614.8. |
| International Search Report and the Written Opinion dated Jan. 26, 2011 for PCT/US2010/058404. |
| International Search Report and Written Opinion dated Jan. 6, 2011 for PCT/US2010/054995. |
| International Search Report and Written Opinion dated Feb. 7, 2011 for PCT/US2010/058453. |
| International Search Report and Written Opinion dated Aug. 1, 2008 for PCT/US2008/051087. |
| International Search Report with Written Opinion dated Aug. 31, 2009 for PCT/US2009/049094. |
| Notice of Allowance dated Jun. 7, 2017 for U.S. Appl. No. 14/162,207. |
| Notice of Allowance dated Sep. 1, 2017 for U.S. Appl. No. 14/162,207. |
| Office Action dated Jan. 27, 2010 for U.S. Appl. No. 12/014,388. |
| Office Action dated Feb. 27, 2018 for U.S. Appl. No. 14/978,925. |
| Office Action dated Apr. 4, 2018 for U.S. Appl. No. 14/845,004. |
| Office Action dated Apr. 22, 2011 for U.S. Appl. No. 12/164,310. |
| Office Action dated Apr. 26, 2018 for U.S. Appl. No. 14/797,533. |
| Office Action dated May 5, 2009 for U.S. Appl. No. 12/014,388. |
| Office Action dated Jun. 9, 2011 for U.S. Appl. No. 12/171,997. |
| Office Action dated Jun. 21, 2010 for U.S. Appl. No. 12/014,388. |
| Office Action dated Aug. 16, 2010 for U.S. Appl. No. 12/164,310. |
| Office Action dated Oct. 20, 2017 for U.S. Appl. No. 15/203,002. |
| Office Action dated Nov. 17, 2017 for U.S. Appl. No. 14/845,004. |
| Office Action dated Dec. 23, 2010 for U.S. Appl. No. 12/014,388. |
| Baxa Corporation Launches PadLock Set Saver for IV Safety press release, 2 pages, available at http://www.pr.com/press-release/55432. ,Oct. 10, 2007. |
| Baxa Corporation Padlock catalog, 3 pages, copyright 2009, available at http://www.baxa.com/SearchResults/ProductDetail/?id=6452BFB9-3048-7B87-701697FB93902BA6. |
| Baxa Corporation Padlock Microbial Testing Technical Paper, copyright 2007, 4 pages, available at http://www.baxa.com/resources/docs/technicalPapers/PadLockMicrobialChallengeTechPaper.pdf. |
| Baxa Corporation PadLock Set Saver Specifications and Instructions for Use, copyright 2007, 2 pages, available at http://www.baxa.com/resources/docs/5300103905C.pdf. |
| BD Q-Syte Luer Access Split Septum product brochure, 4 pages, available at http://www.bd.com/infusion/pdfs/D16333.pdf. ,Nov. 2008. |
| Braun product catalog, 2pages. ,Aug. 2008. |
| Curos Port Protector, web page from http://www.iveramed.com/ ,Jul. 11, 2008. |
| Curos Port Protector product brochure, 2 pages, available at http://www.iveramed.com/clocs/Curos%20Brochure-FINAL.pdf. ,Nov. 2008. |
| Hospira Male/Female Sterile Cap product packaging insert and brochure, 2 pages. ,Aug. 2004. |
| Kippmed Vented Non-Vented Female Luer Lock Caps, The KippGroup, ,Jan. 1995 ,2 pgs. |
| Tego Connector product brochure, 2 pages, available at http://www.icumed.com/Docs-Tego/M1-1148%20TEG0%20Folder%20Brochure%20Rev.3.pdf. ,Nov. 2008. |
| Unomedical Medical Products catalog, 2 pages, available at http://www.unomedical.net/au/section05/section10/LocalSSI/..%5C..%5Cpdf%5Cmedical.pdf ,Jan. 2006. |
| Buchman, et al., A New Central Venous Catheter Cap: Decreased Microbial Growth and Risk for Catheter-Related Bloodstream Infection, The Journal of Vascular Access ,2009 ,11-21. |
| Maki, et al., In Vitro Studies of a Novel Antimicrobial Luer-Activated Needleless Connector for Prevention of Catheter-Related Blookstream Infection, Clinical Infection Diseases, vol. 50, Issue 12 ,Jun. 15, 2010 ,1580-1587. |
| Menyhay, et al., Disinfection of Needleless Catheter Connecors and Access Ports with Alcohol May Not Prevent Microbial Entry: The Promise of a Novel Antiseptic-Barrier Cap, Infection control and Hospital Epidemiology, vol. 27 No. 1 ,Jan. 2006 ,23-27. |
| Stoker, et al., One Less Problem, Safe Practrices when Administering IV Therapy, Managing Infection Control, 4 pgs ,Jun. 2008. |
| International Search Report and Written Opinion dated Feb. 1, 2017 for PCT/US2016/062061. |
| Office Action dated Mar. 27, 2019 for U.S. Appl. No. 14/797,533. |
| Notice of Allowance dated Sep. 17, 2018 for U.S. Appl. No. 14/845,004. |
| Notice of Allowance dated Oct. 25, 2018 for U.S. Appl. No. 14/947,341. |
| Notice of Allowance dated Nov. 9, 2018 for U.S. Appl. No. 15/203,002. |
| Office Action dated Sep. 14, 2018 for U.S. Appl. No. 14/978,925. |
| Office Action dated Nov. 29, 2018 for U.S. Appl. No. 14/797,533. |
| European Search Report dated Jun. 13, 2019 for EP16866954.7. |
| Office Action dated Jun. 3, 2019 for U.S. Appl. No. 14/978,925. |
| Office Action dated Jul. 17, 2019 for U.S. Appl. No. 14/797,533. |
| Number | Date | Country | |
|---|---|---|---|
| 20180256881 A1 | Sep 2018 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62255724 | Nov 2015 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/US2016/062061 | Nov 2016 | US |
| Child | 15979213 | US |